Search Results - "Chervo, María F."

Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy by De Martino, Mara, Tkach, Mercedes, Bruni, Sofía, Rocha, Darío, Mercogliano, María F., Cenciarini, Mauro E., Chervo, María F., Proietti, Cecilia J., Dingli, Florent, Loew, Damarys, Fernández, Elmer A., Elizalde, Patricia V., Piaggio, Eliane, Schillaci, Roxana

“…Stat3 is constitutively activated in several tumor types and plays an essential role in maintaining their malignant phenotype and immunosupression. To take…”
Get full text

Correction: Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer by Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.

Get full text

Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth by Chervo, María F., Cordo Russo, Rosalía I., Petrillo, Ezequiel, Izzo, Franco, De Martino, Mara, Bellora, Nicolás, Cenciarini, Mauro E., Chiauzzi, Violeta A., Santa María de la Parra, Lucía, Pereyra, Matías G., Güttlein, Leandro N., Podhajcer, Osvaldo L., Daniotti, José L., Dupont, Agustina, Barchuk, Sabrina, Figurelli, Silvina, Lopez Della Vecchia, Daniel, Roa, Juan C., Guzmán, Pablo, Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V.

“…Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and lack…”
Get full text

Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer by Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.

“…Triple-negative breast cancer (TNBC) is clinically defined by the absence of estrogen and progesterone receptors and the lack of membrane overexpression or…”
Get full text

Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer? by Cordo Russo, Rosalía I., Chervo, María F., Madera, Santiago, Charreau, Eduardo H., Elizalde, Patricia V.

“…Membrane overexpression of ErbB-2 (MErbB-2), a member of the ErbB family of receptor tyrosine kinases, occurs in 15–20% of breast cancers (BC) and constitutes…”
Get full text

Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis by Madera, Santiago, Chervo, María F., Chiauzzi, Violeta A., Pereyra, Matías G., Venturutti, Leandro, Izzo, Franco, Roldán Deamicis, Agustina, Guzman, Pablo, Dupont, Agustina, Roa, Juan Carlos, Cenciarini, Mauro E., Barchuk, Sabrina, Figurelli, Silvina, Lopez Della Vecchia, Daniel, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Castiglioni, Teresa, Cortese, Eduardo, Ares, Sandra, Deza, Ernesto Gil, Gercovich, Felipe G., Proietti, Cecilia J., Schillaci, Roxana, Cordo Russo, Rosalía I., Elizalde, Patricia V.

“…The hormone receptor-positive (estrogen and/or progesterone receptor (PR)-positive) and HER2-negative breast cancer (BC) subtype is a biologically…”
Get full text

ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy by Elizalde, Patricia V, Cordo Russo, Rosalía I, Chervo, Maria F, Schillaci, Roxana

“…Approximately 15–20% of breast cancers (BC) show either membrane overexpression of ErbB-2 (MErbB-2), a member of the ErbBs family of receptor tyrosine kinases,…”
Get full text

ODP571 Blockade of ErbB-2 Nuclear Function Induces the Interferon Signaling Pathway in Breast Cancer Models Resistant to Trastuzumab by Elizalde, Patricia V, Cordo Russo, Rosalia, Madera, Santiago, Merin, Sharon S, Chervo, María F, Ebrahimie, Esmaeil, Selth, Luke, Chiauzzi, Violeta A, Dupont, Agustina, Barchuk, Sabrina, Figurelli, Silvina, Lopez Della Vecchia, Daniel, Guzmán, Pablo, Roa, Juan C, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Proietti, Cecilia J, Schillaci, Roxana, Hickey, Theresa E, Tilley, Wayne D

“…Abstract ErbB-2, a member of ErbB family of receptor tyrosine kinases, is a key oncogenic driver in breast cancer. Despite clinical efficiency of…”
Get full text

Androgen Receptor Highjacks ErbB-2 Nuclear Function to Induce Triple Negative Breast Cancer Growth by Deamicis, Agustina Roldán, Oakley, Robert H, Helguera, Sergio Andonegui, Lenze, Mariela B, Madera, Santiago, Russo, Rosalia I Cordo, Chervo, María F, Schillaci, Roxana, Fresno, Cristóbal, Cidlowski, John A, Elizalde, Patricia V, Proietti, Cecilia J

“…Abstract Triple negative breast cancer (TNBC) has poor prognosis and neither established biomarkers nor therapeutic targets. On the one hand the androgen…”
Get full text

Abstract 2265: Stat3 and ErbB-2 interaction in breast cancer metastasis by Venturutti, Leandro, Romero, Lucía V., Urtreger, Alejandro J., Chervo, María F., Mercogliano, María F., Cordo Russo, Rosalía I., Pereyra, Matías G., Inurrigarro, Gloria, Díaz Flaqué, María C., Sunblad, Victoria, Roa, Juan C., Guzmán, Pablo, Bal de Kier-Joffe, Elisa, Charreau, Eduardo H., Schillaci, Roxana, Elizalde, Patricia V.

“…Abstract Metastasis is a complex multistep process, responsible for as much as 90% of cancer-related deaths, yet obtaining successful treatment for these…”
Get full text

SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes by Madera, Santiago, Chiauzzi, Violeta A, Chervo, María F, Pereyra, Matías G, Venturutti, Leandro, Deamicis, Agustina Roldán, Dupont, Agustina, Guzmán, Pablo, Roa, Juan C, Cenciarini, Mauro E, Barchuk, Sabrina, Figurelli, Silvina, Vecchia, Daniel Lopez Della, Ares, Sandra, Proietti, Cecilia J, Deza, Ernesto Gil, Gercovich, Felipe G, Schillaci, Roxana, Elizalde, Patricia V, Cordo Russo, Rosalia I

“…Abstract Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically…”
Get full text

Abstract 1558: Deciphering the role of ribosomal paralogs RPL39/RPL39L in metaplastic breast cancer by Chervo, Maria F., li, Main, Mancino, Chiara, Martinez, Karina A. Ortega, Shah, Vrutant V., Qian, Wei, Zhou, Jianying, Guzman-Rojas, Liliana, Matre, Polina, Taraballi, Francesca, Brannan, Kristopher W., Chang, Jenny C.

“…Abstract Metaplastic breast cancer (MpBC) is a rare, highly aggressive, and metastatic malignancy that accounts for <5% of all breast cancer diagnoses. Most…”
Get full text

Abstract 344: Blockade of retrograde transport in triple negative breast cancer excludes ErbB-2 isoforms from the nucleus and abrogates tumor growth by Madera, Santiago, Izzo, Franco, Chervo, Maria F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Montero, Diego, Merin, Sharon, Mercogliano, Maria F., Proietti, Cecilia J., Schillaci, Roxana, Russo, Rosalia I. Cordo, Elizalde, Patricia V.

“…Abstract Triple negative breast cancer (TNBC) is clinically defined by the absence of estrogen and progesterone receptors and the lack of membrane…”
Get full text

Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth by Chervo, Maria F, Parra, Micaela, Bellora, Nicolas, Petrillo, Ezequiel, Madera, Santiago, Deamicis, Agustina Roldan, Mitsuya, Kohzoh, Chiauzzi, Violeta A, Proietti, Cecilia J, Schillaci, Roxana, Huang, Tim H-M, Russo, Rosalia I Cordo, Elizalde, Patricia V

“…Abstract Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and…”
Get full text